Morgan Stanley’s CAMP4 Therapeutics CAMP Stock Holding History
Bought
Maintained
Sold
Other funds holding CAMP
Morgan Stanley's CAMP Position: Q3 2026 in Review
Morgan Stanley increased its CAMP4 Therapeutics (CAMP) stake by 31% in Q3 2026, buying an estimated $14.5K and bringing the position to 14,992 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6514.
Morgan Stanley first reported a position in CAMP in Q4 2024 and has held it in 8 quarters since. The position peaked at $74.4K in Q4 2024. 69 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.
- Morgan Stanley held 14,992 shares of CAMP4 Therapeutics worth $60.6K as of Q3 2026.
- Morgan Stanley bought 3,531 CAMP4 Therapeutics shares in Q3 2026, an estimated $14.5K.
- CAMP4 Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6514 holding.
- Morgan Stanley first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Morgan Stanley's CAMP4 Therapeutics position peaked at $74.4K in Q4 2024.
- 69 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.